Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL490820 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
CoV Replicase polyprotein 1ab/CoV RNA-dependent RNA polymerase/CoV Non-structural protein 15/CoV Non-structural protein 13/Replicase polyprotein 1ab in Severe acute respiratory syndrome coronavirus 2 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523582] [GtoPdb: 3125, 3139, 3206, 3261] [UniProtKB: P0DTD1] | ||||||||
ChEMBL | Inhibition of SARS-CoV-2 3CL protease using HiLyte Fluor488TM-ESATLQSGLRKAK-QXL520TM-NH2 as substrate measured after 5 hrs by FRET assay | B | 6.49 | pIC50 | 320 | nM | IC50 | RSC Med Chem (2023) 14: 9-21 [PMID:36760740] |
ChEMBL | Inhibition of his-tagged SARS CoV-2 main protease expressed in HEK cells using Boc-Abu-Tle-Leu-Gln-AMC as substrate | B | 6.5 | pIC50 | 313 | nM | IC50 | J Med Chem (2022) 65: 9376-9395 [PMID:35709506] |
ChEMBL | Inhibition of SARA-CoV-2 Main protease using Dabcyl-KTSAVLQSGFRKM-E(Edans)-NH2 as substrate by FRET assay | B | 6.6 | pIC50 | 250 | nM | IC50 | Eur J Med Chem (2023) 257: 115491-115491 [PMID:37244162] |
CoV 3C-like (main) protease/CoV Replicase polyprotein 1a in SARS-CoV-2 [GtoPdb: 3111, 3124] [UniProtKB: P0DTC1] | ||||||||
GtoPdb | - | - | 7.3 | pIC50 | 50 | nM | IC50 | MPro Activity Data. postera.ai/covid/activity_data |
CoV 3C-like (main) protease/CoV Replicase polyprotein 1a/SARS coronavirus 3C-like proteinase in Severe acute respiratory syndrome-related coronavirus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3927] [GtoPdb: 3111, 3124] [UniProtKB: P0C6U8] | ||||||||
ChEMBL | Inhibition of SARS 3Clpro measured by rate of reaction | B | 5.16 | pEC50 | 6900 | nM | EC50 | Bioorg Med Chem Lett (2008) 18: 5684-5688 [PMID:18796354] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]